首页 | 本学科首页   官方微博 | 高级检索  
     


Quantitative bioimaging of platinum group elements in tumor spheroids
Authors:Ann-Christin Niehoff,Jonas Grü  nebaum,Aline Moosmann,Dennis Mulac,Judith Sö  bbing,Rebecca Niehaus,Rebecca Buchholz,Sabrina Krö  ger,Arno Wiehe,Sylvia Wagner,Michael Sperling,Hagen von Briesen,Klaus Langer,Uwe Karst
Affiliation:1. Institute of Inorganic and Analytical Chemistry, University of Münster, Corrensstr. 30, 48149 Münster, Germany;2. Department of Pharmaceutical Technology and Biopharmacy, University of Münster, Corrensstr. 48, 48149 Münster, Germany;3. Department of Bioprocessing & Bioanalytics, Fraunhofer Institute for Biomedical Engineering, Joseph-von-Fraunhofer-Weg 1, 66280 Sulzbach, Germany;4. Biolitec Research GmbH, Otto-Schott-Str. 15, 07745 Jena, Germany
Abstract:Limited drug penetration into tumor tissue is a significant factor to the effectiveness of cancer therapy. Tumor spheroids, a 3D cell culture model system, can be used to study drug penetration for pharmaceutical development. In this study, a method for quantitative bioimaging of platinum group elements by laser ablation (LA) coupled to inductively coupled plasma mass spectrometry (ICP-MS) is presented. Different matrix-matched standards were used to develop a quantitative LA-ICP-MS method with high spatial resolution. To investigate drug penetration, tumor spheroids were incubated with platinum complexes (Pt(II)acetylacetonate, cisplatin) and the palladium tagged photosensitizer 5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin (mTHPP). Distribution and accumulation of the pharmaceuticals were determined with the developed method.
Keywords:LA-ICP-MS   Quantification   Tumor spheroids   Pt cytostatics   Photosensitizer
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号